Effective treatment of advanced/metastatic bone and soft tissue sarcomas still represents an unmet medical need. Recent advances in targeted therapies have highlighted the potential of cyclin-dependent kinases (CDK) inhibitors in several cancer types, including sarcomas. CDKs are master regulators of the cell cycle; their dysregulation is listed among the "hallmarks of cancer" and sarcomas are no exception to the rule. In this review, we report both the molecular basis, and the potential therapeutic implications for the use of CDK inhibitors in sarcoma treatment. What is more, we describe and discuss the possibility and biological rationale for combination therapies with conventional treatments, target therapy and immunotherapy, highlighting potential avenues for future research to integrate CDK inhibition in sarcoma treatment.

Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions

Merlini, Alessandra;Pavese, Valeria;Manessi, Giulia;Rabino, Martina;Tolomeo, Francesco;Aliberti, Sandra;D'Ambrosio, Lorenzo;
2023-01-01

Abstract

Effective treatment of advanced/metastatic bone and soft tissue sarcomas still represents an unmet medical need. Recent advances in targeted therapies have highlighted the potential of cyclin-dependent kinases (CDK) inhibitors in several cancer types, including sarcomas. CDKs are master regulators of the cell cycle; their dysregulation is listed among the "hallmarks of cancer" and sarcomas are no exception to the rule. In this review, we report both the molecular basis, and the potential therapeutic implications for the use of CDK inhibitors in sarcoma treatment. What is more, we describe and discuss the possibility and biological rationale for combination therapies with conventional treatments, target therapy and immunotherapy, highlighting potential avenues for future research to integrate CDK inhibition in sarcoma treatment.
2023
Jan 19;13
1
9
cdk inhibitors; cell cycle; cyclin dependent kinases (CDK); sarcoma; target therapy
Merlini, Alessandra; Pavese, Valeria; Manessi, Giulia; Rabino, Martina; Tolomeo, Francesco; Aliberti, Sandra; D'Ambrosio, Lorenzo; Grignani, Giovanni...espandi
File in questo prodotto:
File Dimensione Formato  
fonc-13-1095219.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 866.07 kB
Formato Adobe PDF
866.07 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1893597
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact